CG
AMGN icon

Corundum Group’s Amgen AMGN Stock Holding History

Corundum Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28M Buy
3,637
+358
+11% +$128K 0.43% 50
2025
Q4 		$1.07M Sell
3,279
-247
-7% -$78.4K 0.36% 55
2025
Q3 		$995K Buy
3,526
+8
+0.2% +$2.32K 0.41% 53
2025
Q2 		$982K Buy
3,518
+1,570
+81% +$445K 0.43% 54
2025
Q1 		$607K Sell
1,948
-2,048
-51% -$605K 0.29% 68
2024
Q4 		$1.04M Buy
3,996
+2,030
+103% +$602K 0.39% 66
2024
Q3 		$633K Sell
1,966
-2,147
-52% -$702K 0.29% 66
2024
Q2 		$1.29M Buy
4,113
+2,166
+111% +$636K 0.5% 57
2024
Q1 		$554K Sell
1,947
-144
-7% -$42.1K 0.27% 68
2023
Q4 		$602K Buy
2,091
+123
+6% +$33.5K 0.3% 66
2023
Q3 		$529K Sell
1,968
-428
-18% -$107K 0.3% 66
2023
Q2 		$532K Sell
2,396
-1,818
-43% -$422K 0.27% 74
2023
Q1 		$1.02M Buy
4,214
+1,460
+53% +$358K 0.48% 63
2022
Q4 		$723K Sell
2,754
-1,322
-32% -$354K 0.41% 66
2022
Q3 		$919K Buy
4,076
+150
+4% +$36.4K 0.58% 42
2022
Q2 		$955K Buy
3,926
+311
+9% +$76.2K 0.65% 35
2022
Q1 		$874K Buy
3,615
+1,892
+110% +$435K 0.81% 44
2021
Q4 		$388K Buy
1,723
+480
+39% +$101K 0.25% 74
2021
Q3 		$264K Buy
1,243
+185
+17% +$42.6K 0.2% 86
2021
Q2 		$258K Sell
1,058
-21
-2% -$5.17K 0.17% 87
2021
Q1 		$268K Buy
1,079
+149
+16% +$35.6K 0.21% 76
2020
Q4 		$214K Buy
930
+31
+3% +$7.15K 0.18% 85
2020
Q3 		$228K Buy
+899
New +$223K 0.22% 71
2020
Q1 		– Sell
-973
Closed -$235K – 59
2019
Q4 		$235K Buy
+973
New +$214K 0.25% 62
2019
Q1 		– Sell
-2,790
Closed -$543K – 70
2018
Q4 		$543K Buy
+2,790
New +$544K 0.5% 46

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Corundum Group's AMGN Position: Q1 2026 in Review

Corundum Group increased its Amgen (AMGN) stake by 11% in Q1 2026, buying an estimated $128K and bringing the position to 3,637 shares worth $1.28M. The position accounts for 0.43% of the portfolio, ranked #50.

Corundum Group first reported a position in AMGN in Q4 2018 and has held it in 25 quarters since. The position peaked at $1.29M in Q2 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Corundum Group held 3,637 shares of Amgen worth $1.28M as of Q1 2026.
  • Corundum Group bought 358 Amgen shares in Q1 2026, an estimated $128K.
  • Amgen made up 0.43% of Corundum Group's portfolio in Q1 2026, its #50 holding.
  • Corundum Group first reported a position in Amgen in Q4 2018 and has held it in 25 quarters since.
  • Corundum Group's Amgen position peaked at $1.29M in Q2 2024.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Corundum Group's 13F filing for Q1 2026, filed 20 Apr 2026.